Skip to main content
. 2015 Nov 11;15:895. doi: 10.1186/s12885-015-1899-0

Table 2.

Frequency of autoantibody to CIP2A in sera from patients with lung cancer

Type of diseases No. tested Frequency (Patients with anti-CIP2A/total patients with disease)a
Lung Cancer 105 25.7 %(27/105)**b
Normal human sera (NHS) 82 4.9 % (4/82)**b

a Cutoff value: Mean + 3 SD of NHS

bP value relative to NHS: * p < 0.05; ** p < 0.01